H.C. Wainwright Reiterates Buy Rating, $9 PT on BioCardiAa (BCDA)

March 30, 2022 6:12 AM UTC Send to a Friend
H.C. Wainwright analyst Emanuela Branchetti reiterated a Buy rating and $9.00 price target on BioCardiAa (NASDAQ: BCDA), following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login